Efficacy of antigiardial drugs

Expert Opinion on Drug Safety

Volumn 2, Issue 6, 2003, Pages 529-541

  Wright, Janelle M ^a   Dunn, Linda A ^a   Upcroft, Peter ^a   Upcroft, Jacqueline A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

benzimidazole; drug resistance; Giardia; nitazoxanide; nitroheterocyclic drugs; quinacrine; treatment failures

Indexed keywords

ANTIPROTOZOAL AGENT;

ALTERNATIVE MEDICINE; ANIMAL; ANIMAL DISEASE; DIARRHEA; DRUG EFFECT; DRUG RESISTANCE; GIARDIA; GIARDIASIS; HUMAN; PARASITOLOGY; REVIEW; TREATMENT FAILURE;

ANIMALS; ANTIPROTOZOAL AGENTS; COMPLEMENTARY THERAPIES; DIARRHEA; DRUG RESISTANCE; GIARDIA; GIARDIASIS; HUMANS; TREATMENT FAILURE;

EID: 2142654893     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2.6.529     Document Type: Review

References (118)

1. BROWN D, UPCROFT J, EDWARDS M, UPCROFT P: Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis. Int. J. Parasitol. (1998) 28(1):149-164. (Pubitemid 28082067)
2. HEALEY A, MITCHELL R, UPCROFT J, BOREHAM P, UPCROFT P: Complete nucleotide sequence of the ribosomal RNA tandem repeat unit from Giardia intestinalis. Nucleic Acids Res. (1990) 18(13):4006. (Pubitemid 20222957)
3. UPCROFT J, UPCROFT P: My favourite cell: Giardia. BioEssays (1998) 20:256-263.
4. UPCROFT P, CHEN N, UPCROFT J: Telomeric organization of a variable and inducible toxin gene family in the ancient eukaryote Giardia duodenalis. Genome Res. (1997) 7(1):37-46. (Pubitemid 27095566)
5. UPCROFT P, UPCROFT J: Organization and structure of the Giardia genome. Protist (1999) 150:17-23. (Pubitemid 129756023)
6. FARTHING M: Giardiasis. Gastroenterol. Clin. North Am. (1996) 25(3):493-515.
7. UPCROFT J, UPCROFT P: Giardia: basic biology, genetics and epidemiology. In: Encyclopaedia of Environment Microbiology. Bitton G (Ed.), Wiley Publishers (2002):1469-1477.
8. LUJAN H, MOWATT M, BYRD L, NASH T: Cholesterol starvation induces differentiation of the intestinal parasite Giardia lamblia. Proc. Natl. Acad. Sci. USA (1996) 93(15):7628-7233.
9. UPCROFT P, UPCROFT J: Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin. Microbiol. Rev. (2001) 14(1):150-164. (Pubitemid 32096211)
10. OLSON M, CERI H, MORCK D: Giardia vaccination. Parasitol. Today (2000) 16(5):213-217. (Pubitemid 30216568)
11. BURET A, SCOTT K, CHIN A: Giardiasis: pathophysiology and pathogenesis. In: Giardia:The Cosmopolitan Parasite. Olson B, OlsonM, Wallis P (Eds), CAB International, New York (2002):109-125.
12. THOMSON I, ANDERS R, BHATHAL P: Granulomatous hepatitis and cholangitis associated with giardiasis. Gastroenterology (1982) 83(2):480-483. (Pubitemid 12078238)
13. ROBERTS DM, CRAFT JC, MATHER FJ, DAVIS SH, WRIGHT JA Jr: Prevalence of giardiasis in patients with cystic fibrosis. J. Pediatr. (1988) 112(4):555-559.
14. TURSI A, BRANDIMARTE G, GIORGETTI G: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am. J. Gastroenterol. (2003) 98(4):839-843. (Pubitemid 36576311)
15. SOTTO A, ALVAREZ J, GARCIA B, POMAR F, CENDAN A: Acute hepatic lesion caused by Giardia lamblia. Rev. Esp. Enferm. Dig. (1990) 77(1):24-28.
16. UPCROFT J, MCDONNELL P, GALLAGHER A, CHEN N, UPCROFT P: Lethal Giardia from a wild-caught sulphur-crested cockatoo (Cacatua galerita) established in vitro chronically infects mice. Parasitology (1997) 114:407-412. (Pubitemid 27210008)
17. UPCROFT J, MCDONNELL P, UPCROFT P: Virulent avian Giardia duodenalis pathogenic for mice. Parasitol. Today (1998) 14:281-284. (Pubitemid 28376612)
18. CHEN N, UPCROFT J, UPCROFT P: A Giardia duodenalis gene encoding a protein with multiple repeats of a toxin homologue. Parasitology (1995) 111(Pt 4):423-431.
19. OLSON M, CERI H, MORCK D: Giardia immunoprophylaxis and immunotherapy. In: Giardia: The Cosmopolitan Parasite. Olson B, Olson M, Wallis P (Eds), CAB International, New York (2002):139-155.
20. MOHAMMED S, FAUBERT G: Purification of a fraction of Giardia lamblia trophozoite extract associated with disaccharidase deficiencies in immune Mongolian gerbils (Meriones unguiculatus). Parasite (1995) 2(1):31-39.
21. RAPPUOLI R, LOCHT C, POOLMAN J, ANDRE F, DOUGAN G: European Commission COST/STD Initiative. Report of the expert panel VIII. New vaccines, especially new combined vaccines. Vaccine (1996) 14(7):691-700.
22. TOWNSON S, BOREHAM P, UPCROFT P, UPCROFT J: Resistance to the nitroheterocyclic drugs. Acta Trop. (1994) 56(2-3):173-194. (Pubitemid 24095230)
23. RAETHER W, HANEL H: Nitroheterocyclic drugs with broad spectrum activity. Parasitol. Res. (2003) 90:S19-S39. (Pubitemid 36831290)
24. LOPEZ NIGRO N, GADANO A, CARBALLO M: Evaluation of genetic damage induced by a nitroimidazole derivative in human lymphocytes: tinidazole (TNZ). Toxicol. In Vitro (2001) 15(3):209-213. (Pubitemid 32479200)
25. VOOLMANN T, BOREHAM P: Metronidazole resistant Trichomonas vaginalis in Brisbane. Med. J. Aust. (1993) 159(7):490. (Pubitemid 23300048)
26. BOREHAM P: Giardiasis and its control. Pharm. J. (1991) 234:271-274.
27. PENDLAND S, PISCITELLI S, SCHRECKENBERGER P, DANZIGER L: In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. Antimicrob. Agents Chemother. (1994) 38(9):2106-2110. (Pubitemid 24278809)
28. TOWNSON S, LAQUA H, UPCROFT P, BOREHAM P, UPCROFT J: Induction of metronidazole and furazolidone resistance in Giardia. Trans. R. Soc. Trop. Med. Hyg. (1992) 86(5):521-522.
29. UPCROFT J, UPCROFT P: Drug susceptibility testing of anaerobic protozoa. Antimicrob. Agents Chemother. (2001) 45(6):1810-1814. (Pubitemid 32466353)
30. MÜLLER M: Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery (1983) 93(1 Pt 2):165-171. (Pubitemid 13093128)
31. EDWARDS D: Nitroimidazole drugs-action and resistance mechanisms. II. Mechanisms of resistance. J. Antimicrob. Chemother. (1993) 31:201-210.
32. BROWN D, UPCROFT J, DODD H, CHEN N, UPCROFT P: Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis. Mol. Biochem. Parasitol. (1999) 98(2):203-214. (Pubitemid 29076733)
33. VAN DER WOUDEN E, THIJS J, KUSTERS J, VAN ZWET A, KLEIBEUKER J: Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori. Scand. J. Gastroenterol. (S) (2001) 234:10-14. (Pubitemid 33070906)
34. TOWNSON S, UPCROFT J, UPCROFT P: Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol. Biochem. Parasitol. (1996) 79:183-193. (Pubitemid 26241890)
35. LIU S, BROWN D, O'DONOGHUE P, UPCROFT P, UPCROFT J: Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. Mol. Biochem. Parasitol. (2000) 108:137-140. (Pubitemid 30236324)
36. UPCROFT J, UPCROFT P: Keto-acid oxidoreductase in the anaerobic protozoa. J. Eukaryot. Microbiol. (1999) 46(4):447-449.
37. UPCROFT P: Multiple drug resistance in the pathogenic protozoa. Acta Trop. (1994) 56:195-212. (Pubitemid 24095231)
38. HOMEIDA M, DANESHMEND T, ALI H, KAYE C: Metronidazole metabolism following oral benzoyl metronidazole suspension in children with giardiasis. J. Antimicrob. Chemother. (1986) 18(2):213-219. (Pubitemid 16038791)
39. IYNGKARAN N, LEE I, ROBINSON M: Single dose treatment with Tiberal of Giardia lamblia infection in children. Scand. J. Infect. Dis. (1978) 10(3):243-246. (Pubitemid 9046660)
40. LEVI G, DE AVILA C, AMATO NETO V: Efficacy of various drugs for treatment of giardiasis. A comparative study. Am. J. Trop. Med. Hyg. (1977) 26(3):564-565. (Pubitemid 8136757)
41. KATZ N, CIMERMAN B, ZINGANO A, ZINGANO R, ROCHA R: A clinical trial using secnidazole suspension in children infected with Giardia lamblia. In: Secnidazole: a New Approach to 5-Nitroimidazole Therapy. Katz N, Willis A (Eds), Excerpta Medica, Amsterdam (1989).
42. UPCROFT J, CAMPBELL R, BENAKLI K, UPCROFT P, VANELLE P: Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and-resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob. Agents Chemother. (1999) 43(1):73-76. (Pubitemid 29069202)
43. RODRIGUEZ FERREIRO G, CANCINO BADIAS L, LOPEZ-NIGRO M et al.: DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives. Toxicol. Lett. (2002) 132(2):109-115. (Pubitemid 34607168)
44. BURTIN P, TADDIO A, ARIBURNU O, EINARSON T, KOREN G: Safety of metronidazole in pregnancy: a meta-analysis. Am. J. Obstet. Gynecol. (1995) 172(2 Pt 1):525-529.
45. DIAV-CITRIN O, SHECHTMAN S, GOTTEINER T, ARNON J, ORNOY A: Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology (2001) 63(5):186-192. (Pubitemid 32417247)
46. UPCROFT J, UPCROFT P: Drug resistance and Giardia. Parasitol. Today (1993) 9(5):187-190. (Pubitemid 23126433)
47. HALL A, NAHAR Q: Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans. R. Soc. Trop. Med. Hyg. (1993) 87(1):84-86.
48. EDLIND T, HANG T, CHAKRABORTI P: Activity of the anthelmintic benzimidazole against Giardia lamblia in vitro. J. Infect. Dis. (1990) 162:1408-1411.
49. GOTTSCHALL D, THEODORIDES V, WANG R: The metabolism of benzimidazole anthelmintics. Parasitol. Today (1990) 6(4):115-124.
50. LACEY E: The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. (1988) 18(7):885-936. (Pubitemid 19001491)
51. CHAVEZ B, CEDILLO-RIVERA R, MARTINEZ-PALOMA A: Giardia lamblia: ultrastructural study of the in vitro effect of benzimidazoles. J. Protozool. (1992) 39(4):510-515.
52. UPCROFT J, MITCHELL R, CHEN N, UPCROFT P: Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in β-tubulin. Microb. Drug Resist. (1996) 2(3):303-308.
53. UPCROFT J, CAMPBELL R, UPCROFT P: Quinacrine-resistant Giardia duodenalis. Parasitology (1996) 112:309-313. (Pubitemid 26092396)
54. HARTMAN H, KYSER F: Giardiasis and its treatment. JAMA (1941) 116:2835-2839.
55. GILLIN F, DIAMOND L: Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. J. Antimicrob. Chemother. (1981) 8(4):305-316. (Pubitemid 12201574)
56. NAMGUNG R, RYU J-S, KEE K, SOH C: The effect of metronidazole and quinacrine on the morphology and excystation of Giardia lamblia. Yonsei Rep. Trop. Med. (1985) 16:28644.
57. GENEL F, ERERMIS S, AKSU G, OZTURK C, KUTUKCULER N: Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis. Hum. Psychopharmacol. (2002) 17(7):357-359. (Pubitemid 35189820)
58. DAVIDSON R: Treatment of giardiasis: the North American perspective. In: Human Parasitic Diseases, Giardiasis. Meyer E (Ed.), Elsevier, Amsterdam (1990):325-334.
59. NASH T, OHL C, THOMAS E et al.: Treatment of patients with refractory giardiasis. Clin. Infect. Dis. (2001) 33:22-28. (Pubitemid 32554498)
60. WARHURST D: Antimalarial drugs: mode of action and resistance. J. Antimicrob. Chemother. (1986) 18(Suppl. B):51-59. (Pubitemid 17199051)
61. WARHURST D, THOMAS S: Pharmacology of the malaria parasite-a study of dose-response relationships in chloroquine-induced autophagic vacuole formation in Plasmodium berghei. Biochem. Pharmacol. (1975) 24(22):2047-2056.
62. WEBSTER L: Drugs used in protozoal infections. In: Goodman and Gillman's Pharmacological Basis of Therapeutics. Gilman A, Rall T, Nies A, Taylor P (Eds), Peragmon Press, New York (1960):978-1007.
63. PHILLIPS K, HAILEY F: Furazolidone for treatment of diarrhoeal disease. Trop. Doct. (1987) 17(2):89-91. (Pubitemid 17043285)
64. BROWN D, UPCROFT J, UPCROFT P: A H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis. Eur. J. Biochem. (1996) 241(1):155-161. (Pubitemid 26342984)
65. MORENO S, MASON R, DOCAMPO R: Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. J. Biol. Chem. (1984) 259(10):6298-6305.
66. ORTIZ J, AYOUB A, GARGALA G, CHEGNE N, FAVENNEC L: Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment. Pharmacol. Ther. (2001) 15(9):1409-1415. (Pubitemid 32835549)
67. GILLES HM, HOFFMAN PS: Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol. (2002) 18(3):95-97. (Pubitemid 34164244)
68. ADAGU I, NOLDER D, WARHURST D, ROSSIGNOL J: In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. (2002) 49:103-111. (Pubitemid 34100652)
69. ABBOUD P, LEMÉE V, GARGALA G et al.: Successful treatment of metronidazoleand albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. (2001) 32:1792-1794. (Pubitemid 32532010)
70. ROMERO CABELLO R, GUERRERO L, MUNOZ GARCIA M, GEYNE CRUZ A: Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. R. Soc. Trop. Med. Hyg. (1997) 91(6):701-703. (Pubitemid 28019920)
71. KREUTNER A, DEL BENE V, AMSTEY M: Giardiasis in pregnancy. Am. J. Obstet. Gynecol. (1981) 140:895-901. (Pubitemid 11061676)
72. EDLIND T: Susceptibility of Giardia lamblia to aminoglycoside protein synthesis inhibitors: correlation with rRNA structure. Antimicrob. Agents Chemother. (1989) 33(4):484-489.
73. KATIYAR S, VISVESVARA G, EDLIND T: Comparisons of ribosomal RNA from amitochondrial protozoa: implications for processing, mRNA binding and paromomycin susceptibility. Gene (1995) 152:27-33.
74. O'HANDLEY R: Giardia in farm animals. In: Giardia: The Cosmopolitan Parasite. Olson B, Olson M, Wallis P (Eds), CAB International, New York (2002):97-105.
75. GIANGASPERO A, TRALDI G, PAOLETTI B, TRAVERSA D, BIANCIARDI P: Efficacy of pyrantel embonate, febantel and praziquantel against Giardia species in naturally infected adult dogs. Vet. Rec. (2002) 150(6):184-186. (Pubitemid 34157178)
76. PENGSAA K, LIMKITTIKUL K, POJJAROEN-ANANT C et al.: Single-dose therapy for giardiasis in school-age children. Southeast Asian J. Trop. Med. Public Health (2002) 33(4):711-717.
77. SANGSTER N, GILL J: Pharmacology of anthelmintic resistance. Parasitol. Today (1999) 15(4):141-146. (Pubitemid 29222700)
78. ISAAC-RENTON J, CORDEIRO C, SARAFIS K, SHAHRIARI H: Characterization of Giardia duodenalis isolates from a waterborne outbreak. J. Infect. Dis. (1993) 167(2):431-440. (Pubitemid 23036447)
79. FARBEY M, REYNOLDSON J, THOMPSON R: In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay. Int. J. Parasitol. (1995) 25(5):593-599.
80. GARDNER TB, HILL DR: Treatment of giardiasis. Clin. Microbiol. Rev. (2001) 14(1):114-128. (Pubitemid 32096209)
81. PONCE-MACOTELA M, NAVARRO-ALEGRIA I, MARTINEZ-GORDILLO M, ALVAREZ-CHACON R: In vitro effect against Giardia of 14 plant extracts. Rev. Invest. Clin. (1994) 46(5):343-347.
82. CALZADA F, CERDA-GARCIA-ROJAS C, MECKES M et al.: Geranins A and B, new antiprotozoal A-type proanthocyanidins from Geranium niveum. J. Nat. Prod. (1999) 62(5):705-709. (Pubitemid 29259085)
83. AGARWAL A, SINGH M, GUPTA N et al.: Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana. J. Ethnopharmacol. (1994) 44(3):143-146.
84. TRIPATHI D, GUPTA N, LAKSHMI V, SAXENA K, AGRAWAL A: Antigiardial and immunostimulatory effect of Piper longum on giardiasis due to Giardia lamblia. Phytother. Res. (1999) 13(7):561-565. (Pubitemid 29520930)
85. FARTHING M: Giardia comes of age: progress in epidemiology, immunology and chemotherapy. J. Antimicrob. Chemother. (1992) 30(5):563-566. (Pubitemid 23009002)
86. FARTHING M, INGE P: Antigiardial activity of the bile salt-like antibiotic sodium fusidate. J. Antimicrob. Chemother. (1986) 17(2):165-171. (Pubitemid 16162889)
87. TAKEUCHI T, KOBAYASHI S, TANABE M, FUJIWARA T: In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene. Antimicrob. Agents Chemother. (1985) 27(1):65-70. (Pubitemid 15198156)
88. EDLIND T: Tetracyclines as antiparasitic agents: lipophilic derivatives are highly active against Giardia lamblia in vitro. Antimicrob. Agents Chemother. (1989) 33(12):2144-2145. (Pubitemid 20000153)
89. BELL C, CORY M, FAIRLEY T, HALL J, TIDWELL R: Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrob. Agents Chemother. (1991) 35(6):1099-1107.
90. BOREHAM P, UPCROFT J: The activity of azithromycin against stocks of Giardia intestinalis in vitro and in vivo. Trans. R. Soc. Trop. Med. Hyg. (1991) 85(5):620-621.
91. YOUSSEF M, ESSA M, SADAKA H, EISSA M, RIZK A: Effect of ivermectin on combined intestinal protozoal infection (giardiasis and cryptosporidiosis). J. Egypt. Soc. Parasitol. (1996) 26(3):543-553.
92. NASH T, RICE W: Efficacies of zinc-finger-active drugs against Giardia lamblia. Antimicrob. Agents Chemother. (1998) 42(6):1488-1492. (Pubitemid 28257655)
93. SOUSA M, POIARES-DA-SILVA J: The cytotoxic effects of ciprofloxacin in Giardia lamblia trophozoites. Toxicol. In Vitro (2001) 15(4-5):297-301. (Pubitemid 32889647)
94. JOHNS T, FAUBERT G, KOKWARO J, MAHUNNAH R, KIMANANI E: Anti-giardial activity of gastrointestinal remedies of the Luo of east Africa. J. Ethnopharmacol. (1995) 46(1):17-23.
95. ANDREWS B, MYLVAGANAM H, YULE A: Sensitivity of Trichomonas vaginalis, Tritrichomonas foetus and Giardia intestinalis to bacitracin and its zinc salt in vitro. Trans. R. Soc. Trop. Med. Hyg. (1994) 88(6):704-706.
96. ANDREWS B, PANITESCU D, JIPA G et al.: Chemotherapy for giardiasis: randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin. Am. J. Trop. Med. Hyg. (1995) 52(4):318-321.
97. FAUBERT G: Immune response to Giardia duodenalis. Clin. Microbiol. Rev. (2000) 13(1):35-54. (Pubitemid 30039342)
98. ERLICH J, ANDERS R, ROBERTS-THOMSON I, SCHRADER J, MITCHELL G: An examination of differences in serum antibody specificities and hypersensitivity reactions as contributing factors to chronic infection with the intestinal protozoan parasite, Giardia muris, in mice. Aust. J. Exp. Biol. Med. Sci. (1983) 61(Pt 5):599-615. (Pubitemid 14211108)
99. UNDERDOWN B, ROBERTS-THOMSON I, ANDERS R, MITCHELL G: Giardiasis in mice: studies on the characteristics of chronic infection in C3h/He mice. J. Immunol. (1981) 126(2):669-672. (Pubitemid 11136731)
100. WALTERSPIEL J, MORROW A, GUERRERO M, RUIZ-PALACIOS G, PICKERING L: Secretory anti-Giardia lamblia antibodies in human milk: protective effect against diarrhea. Pediatrics (1994) 93:28-31. (Pubitemid 24012124)
101. GILLIN F: Giardia lamblia: the role of conjugated and unconjugated bile salts in killing by human milk. Exp. Parasitol. (1987) 63:74-83. (Pubitemid 17006809)
102. ANDRZEJEWSKA M, YEPEZ-MULIA L, CEDILLO-RIVERA R et al.: Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyland 2-pentafluoroethylbenzimidazoles. Eur. J. Med. Chem. (2002) 37(12):973-978. (Pubitemid 36349006)
103. BHARTI N, HUSAIN K, GONZALEZ GARZA M et al.: Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett. (2002) 12(23):3478-3478.
104. VALDEZ J, CEDILLO R, HERNANDEZ-CAMPOS A et al.: Synthesis and antiparasitic activity of 1H-benzimidazole derivatives. Bioorg. Med. Chem. Lett. (2002) 12(16):2221-2224. (Pubitemid 34804404)
105. REYNOLDSON J: Therapeutics and new drug targets for giardiasis. In: Giardia: The Cosmopolitan Parasite. Olson B, Olson M, Wallis P (Eds), CAB International, New York (2002):159-175.
106. SANGSTER N, BATTERHAM P, CHAPMAN H et al.: Resistance to antiparasitic drugs: the role of molecular diagnosis. Int. J. Parasitol. (2002) 32(5):637-653. (Pubitemid 34273813)
107. CHEN N, UPCROFT J, UPCROFT P: Physical map of a 2 Mb chromosome of the intestinal protozoan parasite Giardia duodenalis. Chromosome Res. (1994) 2(4):307-313. (Pubitemid 24217393)
108. SANGSTER N: Managing parasiticide resistance. Vet. Parasitol. (2001) 98:89-109. (Pubitemid 32539271)
109. BOREHAM P, PHILLIPS R, SHEPHERD R: The sensitivity of Giardia intestinalis to drugs in vitro. J. Antimicrob. Chemother. (1984) 14:449-461. (Pubitemid 15079024)
110. BOREHAM P, PHILLIPS R, SHEPHERD R: Heterogeneity in the responses of clones of Giardia intestinalis to anti-giardial drugs. Trans. R. Soc. Trop. Med. Hyg. (1987) 81:406-407.
111. MCINTYRE P, BOREHAM P, PHILLIPS R, SHEPHERD R: Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture. J. Pediatr. (1986) 108(6):1005-1010. (Pubitemid 16096832)
112. UPCROFT J, BOREHAM P, CAMPBELL R, SHEPHERD R, UPCROFT P: Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. Acta Trop. (1995) 60(1):35-46.
113. LEMÉE V, ZAHARIA I, NEVEZ G et al.: Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J. Antimicrob. Chemother. (2000) 46(5):819-821.
114. KOORTBEEK L, LIMPER L, TOLBOOM J, NABER A: Giardia lamblia resistance against nitroimidazole; albendazole therapy. In: Giardia-from Molecules to Disease. Thompson R, Reynoldson J, Lymbery A (Eds), CAB International, Wallingford (1994):374.
115. BUTCHER P, CEVALLOS A, CARNABY S et al.: Phenotypic and genotypic variation in Giardia lamblia isolates during chronic infection. Gut (1994) 35(1):51-54. (Pubitemid 24059471)
116. JOKIPII L, JOKIPII A: Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects, and drug absorption and elimination. J. Infect. Dis. (1979) 140(6):984-988. (Pubitemid 10165141)
117. LO LINE MEI C, SANKALE M, PENE P: Les giardiases rebelles. Médecine d'Afrique Noire (1987) 34(12):1063-1068. (Pubitemid 18053936)
118. ROWEDDER A, MEIDER R, WEGMANN W, GYR K: Combined oral and endoscopic mepacrine therapy in therapy-resistant symptomatic giardiasis. Schweiz. Med. Wochenschr. (1991) 121(38):1383-1386.